- Home
- IVA vs NIE Comparison
IVA vs NIE Comparison
Compare IVA & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- NIE
- Stock Information
- Founded
- IVA 2011
- NIE 2007
- Country
- IVA France
- NIE United States
- Employees
- IVA N/A
- NIE N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- NIE Investment Managers
- Sector
- IVA Health Care
- NIE Finance
- Exchange
- IVA Nasdaq
- NIE Nasdaq
- Market Cap
- IVA 769.0M
- NIE 697.2M
- IPO Year
- IVA 2020
- NIE N/A
- Fundamental
- Price
- IVA $6.24
- NIE $25.33
- Analyst Decision
- IVA Strong Buy
- NIE
- Analyst Count
- IVA 7
- NIE 0
- Target Price
- IVA $16.00
- NIE N/A
- AVG Volume (30 Days)
- IVA 61.2K
- NIE 70.5K
- Earning Date
- IVA 09-29-2025
- NIE 01-01-0001
- Dividend Yield
- IVA N/A
- NIE 9.04%
- EPS Growth
- IVA N/A
- NIE N/A
- EPS
- IVA N/A
- NIE N/A
- Revenue
- IVA $19,929,536.00
- NIE N/A
- Revenue This Year
- IVA N/A
- NIE N/A
- Revenue Next Year
- IVA N/A
- NIE N/A
- P/E Ratio
- IVA N/A
- NIE N/A
- Revenue Growth
- IVA N/A
- NIE N/A
- 52 Week Low
- IVA $1.60
- NIE $18.61
- 52 Week High
- IVA $6.55
- NIE $22.47
- Technical
- Relative Strength Index (RSI)
- IVA 60.61
- NIE 62.48
- Support Level
- IVA $5.59
- NIE $24.99
- Resistance Level
- IVA $6.55
- NIE $25.40
- Average True Range (ATR)
- IVA 0.33
- NIE 0.24
- MACD
- IVA 0.01
- NIE 0.01
- Stochastic Oscillator
- IVA 78.02
- NIE 91.75
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.